drugset / Trial / NCT00221871

Proper Dosage of Ketamine in Intravenous Regional Anesthesia

NCT00221871 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Ketamine added to Lidocaine can increase duration of pain relief following intraveonous regional anesthesia (IVRA). The purpose of this dose response study is to determine the minimum effective dosage of intravenous Ketamine, added to 3 mg/kg of Lidocaine. We anticipate that one dosage will provide us with the proper balance between sufficient anesthesia and minimal side effects.

Timeline

Start
2004-01
Primary completion
—
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — Intravenous

Indications

No indication recorded.